According to Abiomed's latest financial reports the company has HK$6.37 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-03-31 | HK$5.93 B | 30.83% |
2021-03-31 | HK$4.53 B | 32.09% |
2020-03-31 | HK$3.43 B | -10.99% |
2019-03-31 | HK$3.86 B | 35.74% |
2018-03-31 | HK$2.84 B | 59.16% |
2017-03-31 | HK$1.78 B | 8.67% |
2016-03-31 | HK$1.64 B | 60.68% |
2015-03-31 | HK$1.02 B | 72.26% |
2014-03-31 | HK$0.59 B | -0.25% |
2013-03-31 | HK$0.59 B | -0.68% |
2012-03-31 | HK$0.59 B | 27.72% |
2011-03-31 | HK$0.46 B | 3.77% |
2010-03-31 | HK$0.45 B | 2.11% |
2009-03-31 | HK$0.44 B | 48.65% |
2008-03-31 | HK$0.29 B | -49.22% |
2007-03-31 | HK$0.58 B | 145.32% |
2006-03-31 | HK$0.23 B | -26.09% |
2005-03-31 | HK$0.32 B | 52.07% |
2004-03-31 | HK$0.21 B | -49.88% |
2003-03-31 | HK$0.42 B | -23.66% |
2002-03-31 | HK$0.55 B | -22.88% |
2001-03-31 | HK$0.72 B | -12.9% |
2000-03-31 | HK$0.82 B | 487.57% |
1999-03-31 | HK$0.14 B | -31.1% |
1998-03-31 | HK$0.20 B | 182.02% |
1997-03-31 | HK$72.53 M | -11.91% |
1996-03-31 | HK$82.34 M |